These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8967971)

  • 1. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.
    Cihlar T; Chen MS
    Mol Pharmacol; 1996 Dec; 50(6):1502-10. PubMed ID: 8967971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase.
    Xiong X; Smith JL; Kim C; Huang ES; Chen MS
    Biochem Pharmacol; 1996 Jun; 51(11):1563-7. PubMed ID: 8630098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase.
    Mendel DB; Cihlar T; Moon K; Chen MS
    Antimicrob Agents Chemother; 1997 Mar; 41(3):641-6. PubMed ID: 9056007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation.
    Xiong X; Smith JL; Chen MS
    Antimicrob Agents Chemother; 1997 Mar; 41(3):594-9. PubMed ID: 9055999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.
    Magee WC; Hostetler KY; Evans DH
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3153-62. PubMed ID: 16048917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of Cytidine, Deoxycytidine, and Their Analog Monophosphates by Human UMP/CMP Kinase Is Differentially Regulated by ATP and Magnesium.
    Hsu CH; Liou JY; Dutschman GE; Cheng YC
    Mol Pharmacol; 2005 Mar; 67(3):806-14. PubMed ID: 15550676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
    Bidanset DJ; Beadle JR; Wan WB; Hostetler KY; Kern ER
    J Infect Dis; 2004 Aug; 190(3):499-503. PubMed ID: 15243923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
    Ruiz JC; Beadle JR; Aldern KA; Keith KA; Hartline CB; Kern ER; Hostetler KY
    Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
    Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
    Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
    Naesens L; Andrei G; Votruba I; Krecmerová M; Holý A; Neyts J; De Clercq E; Snoeck R
    Biochem Pharmacol; 2008 Oct; 76(8):997-1005. PubMed ID: 18773877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of a metabolite of cidofovir from rat kidney.
    Eisenberg EJ; Lynch GR; Bidgood AM; Krishnamurty K; Cundy KC
    J Pharm Biomed Anal; 1998 Apr; 16(8):1349-56. PubMed ID: 9777608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    Ho HT; Woods KL; Bronson JJ; De Boeck H; Martin JC; Hitchcock MJ
    Mol Pharmacol; 1992 Jan; 41(1):197-202. PubMed ID: 1310143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of pyrimidine nucleoside monophosphokinase in normal and malignant tissues.
    Arima T; Akiyoshi H; Fujii S
    Cancer Res; 1977 Jun; 37(6):1593-7. PubMed ID: 192455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
    Kern ER; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Quenelle DC
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3516-22. PubMed ID: 15328119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between pyrimidine nucleoside monophosphate kinase from rat Novikoff ascites hepatoma and rat liver.
    Maness PF; Orengo A
    Cancer Res; 1976 Jul; 36(7 PT 1):2312-6. PubMed ID: 179702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.